Peter Attia· MD
And the same could be true of lactate, right? Yes, absolutely. It's an alternative substrate that doesn't get limited through pyruvate dehydrogenase.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And the same could be true of lactate, right? Yes, absolutely. It's an alternative substrate that doesn't get limited through pyruvate dehydrogenase.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Better than beta-hydroxybutyrate, which also seems to be really beneficial in TBI patients for maybe a different reason than lactate, although it could be all similar, which is if you buy the argument, which I find... that part of the insult of TBI is pyruvate dehydrogenase becomes resistant to insulin.